Alpha | Seeking Options

PRE-MARKET | November 14, 2016 | $AAPL, $KO, $TWTR, $HAR, $X, #TRUMP, #IPHONE7, #traders , $TF_F, $NQ_F

PRE-MARKET | November 14, 2016 | $AAPL, $KO, $TWTR, $HAR, $X, #TRUMP, #IPHONE7, #traders , $TF_F, $NQ_F

by Alpha | Nov 14, 2016 | Pre-Market

PRE-MARKET MOVERS

1. CRBP:

$CRBP Corbus’s lead drug succeeds in mid-stage scleroderma study – Rueters

2. HAR:

$HAR Samsung to Buy U.S. Auto-Parts Supplier Harman for $8 Billion – WSJ

3. EBIO:

$EBIO Eleven Biotherapeutics Swings to Q3 Profit – Street Insider

4. BDC, DGII:

$DGII Digi Rejects $13.82/shr Proposal From Belden $BDC – Quick Facts – RTT

5. MENT:

$MENT Siemens to Buy U.S. Software Maker Mentor for $4.5 Billion – BBG

6. AYA:

$AYA Amaya gets $3.48B offer from former CEO David Baazov – BNN

7. OCUL:

$OCUL Ocular Therapeutix™ Announces Successful Topline Results for Ph 3 Clinical Trial of DEXTENZA™

8. SCLN:

$SCLN Gl Management submit proposal to buyout the Co at $11.18 per share in cash – Reuters

9. TWTR:

$TWTR Twitter Attracts an Activist Investor – Street Insider

10. KATE:

$KATE Kate Spade Receives Letter from Caerus Investors; Recommends Exploring Potential Sale – SI

11. CTL, LVLT:

$CTL Level 3–CenturyLink Merger Looks Smart $LVLT – Barron’s

12. BUD, KO:

$KO Budweiser $BUD and Coca-Cola: a match brewed in heaven – The Telegraph

13. SRPT: $SRPT EU Decision for Translarna Has Positive Read Through for Sarepta – Credit Suisse

14. DIS, NFLX: $NFLX Is Netflix Disney’s $DIS next big buy and is Reed Hastings its next CEO? – TechCrunch

15. GIL: $GIL Gildan Activewear Announces Proposed Acquisition of American Apparel Brand – MarketWired

16. NVS:

$NVS Novartis Said to Hold Talks to Buy Generics Maker Amneal – BBG

17. DVAX:

$DVAX Dynavax says FDA rejects its hepatitis B vaccine – Reuters

UPGRADES

1. ATU:Baird Upgrades Actuant $ATU to Outperform

2. CFX:Argus Upgrades Colfax Corporation $CFX to Buy

3. CHS:Chico’s FAS was Upgraded to a Buy Rating at Wolfe Research $CHS

4. CS:BofA/Merrill Lynch Upgrades Credit Suisse $CS to Buy

5. KSS:Citi Upgrades Kohl’s $KSS to Buy

6. LB:Citi Upgrades L Brands $LB to Buy

7. LMT:$LMT upgraded to Buy at Stifel Nicolaus – PT raise $290 from $260

8. LSXMA:Macquarie Upgrades Liberty SiriusXM $LSXMA to Outperform

9. NRG:UPDATE: UBS Upgrades NRG Energy $NRG to Neutral

10. PF:UPDATE: UBS Upgrades Pinnacle Foods $PF to Buy

11. PLCE:BofA/Merrill Lynch Upgrades The Children’s Place $PLCE to Buy

12. PTCT:Credit Suisse Upgrades PTC Therapeutics $PTCT to Outperform; ROW Translarna Sales Risk Off the …

13. SQ:Square catches upgrade at Pacific Crest

14. X:$X upgraded to Overweight at Morgan Stanley – PT raise $46 from $19

DOWNGRADES

1. C, SEAS:Citigroup Downgrades SeaWorld to Hold $SEAS $C

2. CFG:Sandler O’Neill Downgrades Citizens Financial Group $CFG to Hold

3. CLGX:Piper Jaffray Downgrades CoreLogic $CLGX to Neutral

4. ELY:Compass Point Downgrades Callaway Golf $ELY to Neutral

5. ESPR:Citi Downgrades Esperion Therapeutics $ESPR to Neutral

6. HEAR:B. Riley Downgrades Turtle Beach Corporation $HEAR to Neutral

7. NUE:Berenberg Downgrades Nucor $NUE to Hold Citing Valuation after Sharp Rally

8. RARE:Citi Downgrades Ultragenyx Pharma $RARE to Sell

9. USB:U.S. Bancorp downgraded at Morgan Stanley

10. VIAB:Brean Capital Downgrades Viacom $VIAB to Hold; Merger with CBS Does Not Maximize Value

11. VLY:Sandler O’Neill Downgrades Valley National Bancorp $VLY to Hold

12. WBS:Wells Fargo Downgrades Webster Financial $WBS to Market Perform

13. WERN:Deutsche Bank Downgrades Werner Enterprises $WERN to Hold

14. WSM:Robert W. Baird Downgrades Williams-Sonoma to Hold $WSM

EARNINGS

1. PN:$PN reports FQ3 earnings of 12c EPS and $60.22M Revs –

2. ACM:$ACM reports FQ4 earnings of 65c EPS and $4.32B Revs –

3. STNG:$STNG reports FQ3 earnings of -11c EPS and $114.34M Revs –

4. CRNT:$CRNT reports FQ3 earnings of 6c EPS and $79.13M Revs –

5. TDG:$TDG reports FQ4 earnings of $3.29 EPS and $875.22M Revs –

6. AXAS:$AXAS reports FQ3 earnings of -2c EPS and $13.98M Revs –

7. AXAS:$AXAS reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $1.13M –

Trending Social Alerts

1. DVAX:$DVAX CRL

2. NVDA:$NVDA upgraded to BUY at Needham, price tgt goes to $100

3. PTCT:$PTCT upgraded to Outperform at Credit Suisse, PT $25

4. CRBP:$CRBP Reports Positive Topline Results Showing Clear Signal of Clinical Benefit with Resunab in Phase 2 Study in Systemic Sclerosis

Trending News Headlines

1. Twitter (TWTR) Attracts an Activist Investor

Twitter (NYSE: TWTR) is gaining following a…

2. Dynavax shares fall on FDA rejection of hepatitis b vaccine

Dynavax now says it will need assistance from another drug company or financial partner to resubmit Heplisav-B for another shot at approval.

3. Novartis Said to Hold Talks to Buy Generics Maker Amneal

Novartis AG is in talks to acquire U.S. generic-drugs maker Amneal Pharmaceuticals LLC as the Swiss health-care company seeks to bolster its Sandoz business amid consolidation in the industry, according to people familiar with the matter.

4. Corbus drug succeeds in mid-stage scleroderma study, shares surge

Corbus Pharmaceuticals Holdings Inc said its only drug outperformed a placebo in a mid-stage study involving patients with a form of systemic sclerosis, an incurable autoimmune condition caused by abnormal growth of connective tissue.

5. Corbus Pharmaceuticals Reports Positive Topline Results Showing Clear Signal of Clinical Benefit with Resunab (JBT-101) in Phase 2 Study in Systemic Sclerosis

Corbus Pharmaceuticals Holdings, Inc. , a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, today announced positive topline results from its …

6. UPDATE: Stifel Starts Gilead Sciences (GILD) at Buy

(Updated – November 14, 2016 9:10 AM EST) Stifel initiated coverage on Gilead Sciences (NASDAQ: GILD) with a Buy rating and a price target of $100.Analyst Katherine…

7. CME Said to Consider Dublin for Clearing Amid Brexit Fallout

CME Group Inc. is examining options in Dublin to ensure its clearinghouse keeps access to European Union customers after the U.K. leaves the bloc, according to people familiar with the discussions.

8. Goldman Sees the Possibility of Stagflation Under Trump Presidency

Higher inflation and unemployment.

9. Samsung to Buy U.S. Auto-Parts Supplier Harman for $8 Billion

Samsung said it would buy U.S. auto-parts supplier Harman International Industries for $8 billion in an all-cash deal that instantly makes the South Korean smartphone maker a major player in the world of automotive technology.

Technology News

1. Zuckerberg says he will have more to share soon on updates to address fake news, says FB has to tread carefully

2. Issue isn’t did Facebook impact election. Underlying question is whether it has responsibility to block known lies

3. I talked to Y Combinator and @torbahax about the Trump-related social media harassment that got him kicked out of YC

4. Facebook sacked staff who worked on ‘trending topics’ because of bias, but now its algorithms can’t filter fake news

5. This from Facebook is absolute chickenshit.

6. Facebook is embroiled in accusations that it helped spread fake news stories that influenced how Americans voted.

7. AFF hacked, 103m passwords were stored in plain text, 232m SHA1’ed – 99.3% now cracked –

8. Funny how alt-right idiots mock minority fear, yet can’t handle any discomfort themselves:

9. The extortion economy is strong, but lets not call them “researchers”:

10. As expected, battery life on the low end 13” is measurably better than the touch bar models.

PRE-MARKET | November 10, 2016 | Early movers: $KSS, $MET, $COP, $PRTY, $BBY, $CAS, $SHAK, $TWTR, $MYL #Post #ELECTIONS

PRE-MARKET | November 10, 2016 | Early movers: $KSS, $MET, $COP, $PRTY, $BBY, $CAS, $SHAK, $TWTR, $MYL #Post #ELECTIONS

by Alpha | Nov 10, 2016 | Pre-Market

PRE-MARKET MOVERS

1. SODA:

$SODA SodaStream Q3 Earnings, Sales Beat Estimates – Zacks

2. ZLTQ:

$ZLTQ ZELTIQ Aesthetics Inc. Is Up After Q3 Earnings Surpassed Expectations – RTT

3. ADAP:

$ADAP FDA lifts clinical hold on Adaptimmune cancer trial – Fierce Biotech

4. SHAK:

$SHAK Shake Shack Stock Soars As Profit Doubles – Fox Biz

5. TASR:

$TASR Taser’s Quarterly Profit More Than Doubles – WSJ

6. OMER:

$OMER Omeros Corporation Reports Third Quarter 2016 Financial Results – Biz Wire

7. RL:

$RL Ralph Lauren Tops Q2 EPS by 19c – Street Insider

8. PFE:

$PFE Pfizer wins EU’s approval for Ibrance as Novartis readies rival drug – Reuters

9. PFE:

$PFE Pfizer weighs sale or spin-off of consumer health unit – sources – Reuters

10. TSLA:

$TSLA Tesla’s own numbers show Autopilot has higher crash rate than human drivers – GreenCarReports

11. COP:

$COP ConocoPhillips cuts budget 4 percent, to buy back $3 billion in shares – Reuters

12. YHOO:

$YHOO Yahoo Says Investigating Claim of New Hack of User Data – BBG

13. SCTY:

$SCTY SolarCity’s Hot Third Quarter Shows Why Tesla Wants In – Fortune

14. MYL:

$MYL Mylan ticks higher after reporting earnings and reaffirming guidance – CNBC

15. ALXN:

$ALXN Alexion Pharma to delay quarterly results – MarketWatch

16. GE:

$GE General Electric CEO Immelt Buys 50K Shares – Street Insider

17. VRX:

$VRX Valeant Has Been Subpoenaed Over Its Pharmacy Activities – Fortune

18. MACK:

$MACK Merrimack Pharma Tops Q3 EPS by 4c; Lowers, Narrows FY16 Outlook – SI

19. TWTR:

$TWTR Twitter says COO Adam Bain to leave, Noto to take his place – Reuters

20. TWTR:

$TWTR Twitter Keeps Finding Ways to Look Dysfunctional – BBG Gadfly

21. CCE:

$CCE Coca-Cola European Partners Q3 EPS eur 0.67 – Reuters

22. SLCA:

$SLCA U.S. Silica Prices Public Offering of Common Stock – Nasdaq Read more:

23. AZN:

$AZN AstraZeneca Stocks Slips As Q3 Crestor Sales, Earnings Disappoint – TheStreet

24. TROV:

$TROV TrovaGene Reports Wider-than-Expected Loss in Q3 – Zacks

25. SEDG, SPWR:

$SEDG Solaredge Technologies Inc, SunPower $SPWR Corporation Shares Move Lower On Earnings – ValueWalk

26. NVAX:

$NVAX Novavax Posts Mixed Q3 Results, Announces Restructuring And Update On RSV Program – Benzinga

27. BVX:

$BVX Bovie Medical Announces Primary and Secondary Offerings of Common Stock – Biz Wire

28. AVID:

$AVID Avid Technology Misses Q3 EPS by 19c; Guides Below – Street Insider

29. HLIT:

$HLIT Harmonic Inc. Is Pulling Back After Q3 Loss – RTT

30. ANTH:

$ANTH Anthera Pharma Announces CHABLIS-SC1 Trial Missed Primary Endpoint in Active SLE – SI

UPGRADES

1. ABC:Morgan Stanley Upgrades AmerisourceBergen $ABC to Overweight

2. CHK:$CHK – upgraded to Hold at Jefferies

3. CHTR:MoffettNathanson Upgrades Charter Communications $CHTR to Buy

4. LLL:Barclays Upgrades L-3 Communications $LLL to Overweight

5. LMT:Lockheed Martin Corp. was Upgraded to a Hold Rating at Barclays $LMT

6. LPLA:UBS Upgrades LPL Investment $LPLA to Neutral

7. MPAA:B. Riley Upgrades Motorcar Parts Of America to Buy $MPAA

8. MSFT:Atlantic Equities Upgrades Microsoft $MSFT to Neutral

9. NFX:Societe Generale Upgrades Newfield Exploration $NFX to Buy

10. NOC:$NOC upgraded to Overweight at Barclays – PT raise $270 from $230

11. OAS:Deutsche Bank Upgrades Oasis Petroleum $OAS to Buy

12. PCLN:$PCLN upgraded to Buy at Stifel Nicolaus – PT raise $1.9k from $1.65

13. STON:Raymond James Upgrades Stonemor Partners $STON to Outperform

14. WFT:CLSA Upgrades Weatherford International $WFT to Buy

DOWNGRADES

1. AGFS:Citi Downgrades AgroFresh Solutions $AGFS to Neutral

2. BAS:Deutsche Bank Downgrades Basic Energy Services $BAS to Hold

3. BEAV:Deutsche Bank Downgrades BE Aerospace $BEAV to Hold

4. BEN:Deutsche Bank Downgrades Franklin Resources $BEN to Sell

5. CSX:BMO Capital Downgrades CSX $CSX to Market Perform

6. HOMB:Keefe, Bruyette & Woods Downgrades Home Bancshares $HOMB to Market Perform

7. KND:Kindred Healthcare was Downgraded to a Hold Rating at RBC Capital $KND

8. MS, VRX:Rodman downgrades $vrx to neutral. $ms cuts PT from $42 to $25.

9. RUN:JMP Securities Downgrades Sunrun $RUN to Market Perform

10. SEDG:JMP Securities Downgrades SolarEdge Technologies $SEDG to Market Perform

11. VRX:$VRX downgraded to Neutral at Rodman & Renshaw – PT cut $23 from $81, maintains Overweight rating at Morgan Stanley – PT cut $25 from $42

12. VSLR:JMP Securities Downgrades Vivint Solar $VSLR to Market Perform

13. WCG:JPMorgan Downgrades WellCare Health Plans $WCG to Neutral

14. WK:Credit Suisse Downgrades Workiva $WK to Neutral

EARNINGS

1. NAT:$NAT reports FQ3 earnings of -8c EPS and $45.86M Revs –

2. NICE:$NICE reports FQ3 earnings of 83c EPS and $240.29M Revs –

3. AZN:$AZN reports FQ3 earnings of $1.32 EPS and $5.70B Revs –

4. PRGO:$PRGO reports FQ3 earnings of $1.65 EPS and $1.33B Revs –

5. WIX:$WIX reports FQ3 earnings of -4c EPS and $75.61M Revs –

6. HIMX:$HIMX reports FQ3 earnings of 12c EPS and $218.08M Revs –

7. GLF:$GLF reports FQ3 earnings of $-1.05 EPS and $27.82M Revs –

8. MMS:$MMS reports FQ4 earnings of 77c EPS and $623.09M Revs –

9. BCEI:$BCEI reports FQ3 earnings of -35c EPS and $49.33M Revs –

10. PRTY:$PRTY reports FQ3 earnings of 12c EPS and $556.95M Revs –

11. PRTY:$PRTY reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $20.77M –

12. KSS:$KSS reports FQ3 earnings of 80c EPS and $4.33B Revs –

13. VSTO:$VSTO reports FQ2 earnings of 74c EPS and $684.31M Revs –

14. BRKS:$BRKS reports FQ4 earnings of 22c EPS and $157.55M Revs –

15. SODA:$SODA reports FQ3 earnings of 69c EPS and $124.23M Revs –

16. CCE:$CCE reports FQ3 earnings of 72c EPS and $3.26B Revs –

17. RL:$RL reports FQ2 earnings of $1.90 EPS and $1.82B Revs –

18. PNK:$PNK reports FQ3 earnings of -1c EPS and $595.17M Revs –

Trending Social Alerts

1. BMY:Bristol-Myers hands over $100M in cash for a new fibrosis drug, beefing up NASH focus $BMY

2. ANTH:$ANTH Blisibimod CHABLIS-SC1 Phase 3 Study Did Not Achieve the Primary Endpoint in Patients With Active Systemic Lupus Erythematosus #Fail

3. HALO:$HALO Announces Broad Clinical Collaboration Agreement To Evaluate PEGPH20 And Tecentriq In Up To Eight Tumor Types

4. IBB:$XBI up 2.7% $IBB up 1.93% in pm

5. SODA:$SODA Reports Q3 EPS $0.69 vs. Est. $0.23, Rev. $124.2M vs. Est. $115M – double digit growth 🙂

6. SGEN:$SGEN Receives FDA Breakthrough Therapy Designation for ADCETRIS® in Mycosis Fungoides & Primary Cutaneous Anaplastic Large Cell Lymphoma

7. MNKD:.@AdamSinger Neither do I, but it’s a bizarre announcement. Does $MNKD have compromising photos or similar?

8. CELG:@tgtxdough $IBB $CELG coiled spring of money flow may need to shift back over to biotech.

9. KSS:Kohl’s Reports Q3 Adj. EPS $0.80 vs $0.70 Est., Sales $4.327B vs $4.33B Est. $KSS

10. M:$KSS Father Christmas makes a bear skin rug. $M up next…

11. TUBE:$TUBE Adobe $ADBE to acquire TubeMogul for $14/sh

12. RDHL:$RDHL Reports Positive FDA Type B Meeting on RHB-105 for H. Pylori Infection Ahead of Confirmatory Phase III Study

Trending News Headlines

1. Six thoughts on President Trump and the durability of the biotech stock rally

Investors have convinced themselves that President Donald Trump is going to make drug stocks great again. Will it last?

2. Bristol-Myers hands over $100M in cash for a new fibrosis drug, beefing up NASH focus

It’s not all checkpoints all the time at Bristol-Myers Squibb. The big biotech has been ramping up an ambitious effort in fibrosis and NASH and this morning it’s taking the wraps off another deal in the field, paying $100 million to Japan’s Nitto Denko for an early-stage drug candidate that

3. Opdivo (nivolumab) Demonstrates Overall Survival Benefit in Patients With Unresectable Advanced or Recurrent Gastric Cancer in Phase 3 Study

Opdivo is the first and only Immuno-Oncology agent to demonstrate overall survival advantage in patients with unresectable advanced or recurrent gastric cancer refractory to, or intolerant of, standard therapy Bristol-Myers Squibb Company (NYSE:BMY) announced today that ONO-4538-12, a Phase 3, randomized, double-blind clinical trial evaluating the efficacy and safety of Opdivo (nivolumab) in patients with unresectable advanced or recurrent gastric cancer refractory to, or intolerant of, standard therapy, met its primary endpoint of overall survival (OS). Ono Pharmaceutical Co. Ltd. of Japan , Bristol-Myers Squibb’s development partner for Opdivo , conducted the ONO-4538-12 trial. The companies will work with investigators on the future presentation of the study results. Fouad Namouni, M.D., head of development, Oncology, Bristol-Myers Squibb, commented, “Patients with advanced or recurrent gastric cancer generally have a poor prognosis, and there are currently no standard-of-care

4. Halozyme Announces Broad Clinical Collaboration Agreement To Evaluate PEGPH20 And Tecentriq In Up To Eight Tumor Types

Phase 1b/2 studies will evaluate Halozyme’s investigational drug, PEGPH20 with Genentech’s anti-PDL1 Tecentriq® (atezolizumab) Halozyme Therapeutics, Inc. (NASDAQ: HALO), an oncology biotech developing novel oncology and drug-delivery therapies, and Genentech, a member of the Roche Group , today announced an agreement to collaborate on clinical studies evaluating up to eight different tumor types beginning in 2017. The first study will be a Phase 1b/2 open-label, multi-arm randomized global study, led by Genentech to evaluate their cancer immunotherapy Tecentriq® (atezolizumab), an anti-PD-L1 monoclonal antibody, in combination with Halozyme’s investigational drug, PEGPH20 in six tumor types. Halozyme will supply drug only for the Genentech study. This study will have an initial focus on gastrointestinal malignancies, including pancreatic and gastric cancers. The second study will be a Phase 1b open-label randomized study led by Halozyme to assess Tecentriq in combination with PEGPH20

5. Andy Biotech on Twitter

“$AZN discontinues its Anti-CD19 in DLBCL and Anti-ANG2 in solid tumors. $JUNO $KITE $SGEN $XNCR”

6. Katy Perry Ditches Alibaba’s Concert After Anti-Trump Tweets

Pop star Katy Perry has pulled out of a star-studded extravaganza put on by China’s largest online retailer.

7. Tesla’s own numbers show Autopilot has higher crash rate than human drivers

A couple of weeks ago, I wrote about Tesla’s claim that its Autopilot driver-assistance software is safer than a human driver. After a fatal Autopilot crash last May, the company said the death was the first in 130 million miles of Autopilot driving—and noted that, “among all…

8. AstraZeneca sees big healthcare changes under Trump

Drugmaker AstraZeneca (AZN.L) expects major U.S. healthcare changes after Donald Trump’s election victory but its chief executive warned on Thursday that pricing pressures in the world’s biggest drugs market would not go away.

9. IEA sees global market awash with oil in 2017 if no OPEC cut

The oil market risks running another surplus in 2017 without an output cut from OPEC, as producers around the globe ramp up supply and demand growth falters, the International Energy Agency said on Thursday.

10. U.S. should have joined China-led infrastructure bank: Trump adviser

A top adviser of U.S. President-elect Donald Trump lashed out at the Obama administration for failing to embrace the China-led Asian Infrastructure Investment Bank (AIIB), suggesting a possible policy shift when Trump takes office in January.

Technology News

1. It’s about time you got to know a bit about Mike Pence—and how terrible he’d be for Silicon Valley:

2. Reminder: Facebook has created a product that has made it profitable for people to lie to you with fake news.

3. The future of news: Macedonian schoolchildren making $$$ by writing fake pro-Trump stories that go viral on Facebook

4. Trump, when asked about hacking his political enemies, said “I wish I had that power.” With NSA, he’ll soon will.

5. Trump’s NASA looks good for human space exploration and terrible for Earth science

6. A Silicon Valley investor said he wanted California to become its own nation if Trump won

7. Donald Trump’s win is a reminder of Facebook’s power to transform society, and often not for the better

8. “the best way to generate shares on Facebook is to publish sensationalist and often false content”

9. Silicon Valley and tech industry’s relationship with government is set to shift under Trump. @fmanjoo examines how:

10. I wrote a thing about Silicon Valley getting blindsided, and where tech goes from here

Early movers: KSS, MET, COP, PRTY, BBY, CAS, SHAK, TWTR, MYL & more

Check out which companies are making headlines before the bell: Kohl’s – The retailer reported adjusted quarterly profit of 80 cents per share, 10 cents a share above forecasts. Revenue was very slightly above estimates. Same-store sales did fall by 1.7 percent, but that drop was in line with analysts’ projections.

PRE-MARKET | November 09, 2016 | $SPX, $ES_F, $GDX, $TLT, $HTZ, #TRUMP, #Traders, #Options, $JAZZ, $FSLR, $CROX

PRE-MARKET | November 09, 2016 | $SPX, $ES_F, $GDX, $TLT, $HTZ, #TRUMP, #Traders, #Options, $JAZZ, $FSLR, $CROX

by Alpha | Nov 9, 2016 | Pre-Market

PRE-MARKET MOVERS

1. CXW, GEO:

$CXW Corrections Corp., GEO Group ) Advance Following Trump Victory – SI

2. BMY, INFI:

$INFI Bristol-Myers Squibb $BMY and Infinity Pharmaceuticals Announce Clinical Collaboration – BW

3. SAEX:

$SAEX SAExploration wins West Africa work – Upstream

4. GTT:

$GTT GTT Communications Tops Q3 EPS by 6c – Street Insider

5. ARIA:

$ARIA ARIAD Pharma Announces Publication of Brigatinib Phase 1/2 Data; Median PFS Observed at 1+ Year

6. ARIA:

$ARIA ARIAD subpoenaed regarding financial assistance to Medicare patients – SA

7. KITE:

$KITE Kite Pharma Reports Third Quarter 2016 Financial Results – Biz Wire

8. IONS:

$IONS Ionis Pharmaceuticals Reports Financial Results and Highlights for Third Quarter 2016 – PRN

9. INO:

$INO Inovio Reports Wider Loss in Q3, Revenues Beat – Zacks

10. VSAT:

$VSAT ViaSat Posts Earnings in Q2, Revenues Top Estimates – Nasdaq Read more:

11. ASH: $ASH Ashland Global Holdings reports Q4 loss per share of $4.46 – Reuters

12. ILG: $ILG ILG Reports Third Quarter 2016 Results – Business Wire

13. JAZZ: $JAZZ Jazz Pharmaceuticals Misses Q3 EPS by 4c; Guides In-Line – Street Insider

14. HTZ:

$HTZ Icahn Snaps Up Falling Hertz Shares – WSJ

15. DISH:

$DISH DISH Network Lags Q3 Earnings Lags Revenues – Nasdaq

16. CROX:

$CROX Crocs Q3 Net Loss Narrows – Nasdaq

17. RVLT:

$RVLT Revolution Lighting Technologies Reports Third Quarter 2016 Financial Results – MarketWired

18. COTY:

$COTY Coty’s revenue misses on weak demand for perfumes, cosmetics – Reuters

19. MPSX:

$MPSX Multi Packaging Solutions Completes Two Strategic Acquisitions: AJS Labels and i3 Plastic Cards

20. MPSX:

$MPSX Multi Packaging Solutions International Q1 EPS of $0.17 per share – Reuters

21. GMED:

$GMED Globus Medical Inc. Is Down After Q3 Revenues Missed – RTT

22. GPRO:

$GPRO GoPro is recalling the Karma drone after just 16 days on the market – TechCrunch

23. KOPN:

$KOPN Kopin Corp to Delay Form 10-Q; Employee May Have Embezzled Money at Subsidiary – Street Insider

24. TRIP:

$TRIP TripAdvisor revenue misses estimates as referral income falls – Reuters

25. IPXL:

$IPXL Impax Laboratories Misses Q3 EPS by 2c – Street Insider

26. ARWR:

$ARWR Arrowhead sneaks out pre-election clinical hold news on Hep B candidate – Fierce Biotech

UPGRADES

1. ABC:Mizuho Securities Upgrades AmerisourceBergen $ABC to Buy Following Trump Win

2. AGTC:$AGTC upgraded to Buy From Neutral by Roth Capital. PT $15

3. ARR:Nomura Holdings Upgrades Armour Res. to Hold $ARR

4. ASCMA:Imperial Capital Upgrades Ascent Media $ASCMA to Outperform

5. BWXT:Drexel Hamilton Upgrades BWX Technologies $BWXT to Buy

6. CMC:Jefferies Upgrades Commercial Metals Company $CMC to Buy Following Trump Win

7. CPA:Deutsche Bank Upgrades Copa Holdings $CPA to Buy

8. DEPO:$DEPO upgraded to Buy From Neutral by Mizuho

9. ESTE:Seaport Global Securities Upgrades Earthstone Energy $ESTE to Buy

10. FFIV:F5 Networks was Upgraded to a Hold Rating at Nomura Holdings $FFIV

11. GOLD:BMO Capital Upgrades Randgold Resources Ltd. $GOLD to Outperform

12. LMT:Deutsche Bank Upgrades Lockheed Martin $LMT to Buy

13. MCK:Mizuho Securities Upgrades McKesson $MCK to Buy Following Trump Win

14. NUE:BofA/Merrill Lynch Upgrades Nucor $NUE to Buy

15. X:Jefferies Upgrades US Steel $X to Buy Following Trump Win

DOWNGRADES

1. AMED:Mizuho Securities Downgrades Amedisys to Hold $AMED

2. AXL:Merrill Lynch Downgrades American Axle to Sell $AXL

3. BWA:BofA/Merrill Lynch Downgrades BorgWarner $BWA to Underperform

4. DLPH:Merrill Lynch Downgrades Delphi Automotive to Sell $DLPH

5. GPRO:Raymond James Downgrades GoPro $GPRO to Market Perform

6. HCA:Mizuho Securities Downgrades HCA Holdings to Hold $HCA

7. KEY:Susquehanna Downgrades KeyCorp $KEY to Neutral

8. LNC:FBR Capital Downgrades Lincoln National Corp. to Hold $LNC

9. MMS:Raymond James Downgrades MAXIMUS, Inc. $MMS to Market Perform

10. SHLX:Shell Midstream was Downgraded to a Hold Rating at Barclays $SHLX

11. THC:Merrill Lynch Downgrades Tenet Healthcare to Hold $THC

12. UHS:Merrill Lynch Downgrades Universal Health to Hold $UHS

13. UNH:Mizuho Securities Downgrades UnitedHealth to Hold $UNH

14. VOYA:RBC Capital Downgrades Voya Financial $VOYA to Outperform

EARNINGS

1. BDSI:$BDSI reports FQ3 earnings of -30c EPS and $3.57M Revs –

2. BDSI:$BDSI misses the Estimize EPS Consensus by 5c and reports inline with the Estimize Revenue Consensus –

3. ENR:$ENR reports FQ4 earnings of 54c EPS and $432.40M Revs –

4. EVEP:$EVEP reports FQ3 earnings of -38c EPS and $51.37M Revs –

5. HMSY:$HMSY reports FQ3 earnings of 24c EPS and $124.60M Revs –

6. STON:$STON reports FQ3 earnings of -32c EPS and $78.54M Revs –

7. DISH:$DISH reports FQ3 earnings of 64c EPS and $3.75B Revs –

8. SCMP:$SCMP reports FQ3 earnings of 28c EPS and $57.87M Revs –

9. CCO:$CCO reports FQ3 earnings of -7c EPS and $673.06M Revs –

10. NCLH:$NCLH reports FQ3 earnings of $1.62 EPS and $1.49B Revs –

11. VIAB:$VIAB reports FQ4 earnings of 69c EPS and $3.23B Revs –

12. IPXL:$IPXL reports FQ3 earnings of 37c EPS and $227.91M Revs –

13. ACAT:$ACAT reports FQ2 earnings of -88c EPS and $164.61M Revs –

14. KERX:$KERX reports FQ3 earnings of -39c EPS and $6.34M Revs –

15. WAC:$WAC reports FQ3 earnings of -17c EPS and $297.33M Revs –

16. WEN:$WEN reports FQ3 earnings of 11c EPS and $364.01M Revs –

17. WEN:$WEN reports inline with the Estimize EPS Consensus and beats the Estimize Revenue Consensus by $11.16M –

18. CROX:$CROX reports FQ3 earnings of -3c EPS and $245.89M Revs –

19. IONS:$IONS reports FQ3 earnings of 6c EPS and $110.93M Revs –

20. INO:$INO reports FQ3 earnings of -28c EPS and $12.54M Revs –

21. STKL:$STKL reports FQ3 earnings of 7c EPS and $348.73M Revs –

22. PMC:$PMC reports FQ3 earnings of 44c EPS and $512.60M Revs –

23. TRCO:$TRCO reports FQ3 earnings of 48c EPS and $518.07M Revs –

24. COTY:$COTY reports FQ1 earnings of 23c EPS and $1.08B Revs –

25. MEG:$MEG reports FQ3 earnings of 19c EPS and $377.36M Revs –

26. MPAA:$MPAA reports FQ2 earnings of 64c EPS and $112.38M Revs –

27. ELOS:$ELOS reports FQ3 earnings of 8c EPS and $71.55M Revs –

Trending Social Alerts

1. KITE:$KITE — KTE-C19 BLA to be submitted in Q1 ’17.

2. INFI:$BMY and $INFI Announce Clinical Collaboration to Evaluate Opdivo in Combination with IPI-549 in Advanced Solid Tumors

3. ES_F:Brexit vs Trump $ES_F $SPY

4. CELG:$CELG bidding 112 up 4 bucks $IBB 277 bid up 15. $GILD up 2

5. GPRO:$GPRO GoPro is recalling the Karma drone after just 16 days on the market – TechCrunch

6. GEO:Prison Stocks Spike 15-20% Following Trump Victory $CXW $GEO

7. IBB:massive victory for #biotech last $IBB +12 already pre market

8. XBI:$XBI up 6%!

9. MRK:Hopes that #presidenttrump will go easy on them has drugmakers rallying: $pfe up 5% $mrk up 2.7% $jnj up 2.3%

10. ARIA:In other news last night… $ARIA gets subpoena from US Attorney MA related to patient support programs, $ARWR ph2 HepB study clinical hold.

11. HCA:holy cow. $HCA down 16%

Trending News Headlines

1. Biotech Stocks Surge on Trump Victory (XBI) (IBB)

Biotech stocks are surging in pre-open trade on Trump Win. Trump is viewed as potentially less onerous than Clinton on drug pricing.XBI (NYSE: XBI) is up…

2. The Associated Press on Twitter

“BREAKING: Donald Trump is elected president of the United States.”

3. dough on Twitter

“BMO TRUMP no more obamacare = positive for major pharma $MRK $BMY $PFE $CELG $GILD”

4. Kite Pharma Reports Third Quarter 2016 Financial Results | Business Wire

Kite Pharma, Inc. (Nasdaq: KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous cell therapy (eACT™) pr

5. ASH Abstract Confirms Positive Outlook For Actinium’s Actimab-A

AML, Actimab-A, ATNM, ASH

6. Hospital Stocks Slammed on Trump Victory (HCA) (THC) (UHS)

Hospital stocks are bid sharply lower on a Trump victory. Trump is seen overturning Obamacare, which would be seen as negative for the hospitalsHCA Holdings (NYSE: HCA)…

7. Eric Scott Hunsader on Twitter

“Brexit vs Trump $ES_F $SPY”

Technology News

1. Facebook threatens LinkedIn with job opening features

2. Facebook takes a break from copying Snapchat

3. The most exciting part about the fun new photo filter in Facebook’s mobile app is the AI that underpins it:

4. Thinking about what I am going to tell my children at breakfast tomorrow.

5. Lattes raining down from the sky. Google drone project nixed planned delivery partnership with Starbucks

6. Little scoop from last night. Not a full acquisition, but I confirmed Apple did buy parts of Omnifone this year

7. Reporters buy web browsing history of 3 million people inc 10 billion URLs & re-identify some users

8. GoPro is recalling its Karma drone – Company needs new CEO and management, repeated failures on product execution.

9. Another Alphabet moonshot goes off orbit. via @TechBhurji

10. It’s now 5-7 years between when a new technology is introduced and when it changes society in a fundamental way

If you enjoy the content at SeekingOptions, please like our Facebook page and subscribe to our Youtube Channel

See you in the chat room

PRE-MARKET | November 08, 2016 | $ACAD, $MOMO, $PCLN, $JCI, $GS, #electionday, #election2016, #options

PRE-MARKET | November 08, 2016 | $ACAD, $MOMO, $PCLN, $JCI, $GS, #electionday, #election2016, #options

by Alpha | Nov 8, 2016 | Pre-Market

PRE-MARKET MOVERS

1. ACAD:

$ACAD Quarterly Financial Update for ACADIA Pharmaceuticals Inc.

2. MOMO:

$MOMO on Earnings

3. PCLN:

$PCLN Offers Weak Q4 Outlook, But Shares Jump 5% Anyway

4. JCI:

$JCI Q4 Earnings Beats Estimates – November 8, 2016 –

5. JCI:

$JCI Q4 Earnings Beats Estimates – November 8, 2016 –

6. DEPO:

$DEPO swings and misses on Earnings.

7. RMTI:

$RMTI Earnings and No Triferic Sales

UPGRADES

1. ACAD:ACADIA Pharmaceuticals was Upgraded to a Buy Rating at Merrill Lynch $ACAD

2. DLR:Morgan Stanley Upgrades Digital Realty Trust $DLR to Overweight

3. ETE:Bernstein Upgrades Energy Transfer Equity, L.P. $ETE to Outperform

4. IAG:TD Securities Upgrades IAMGOLD $IAG to Buy

5. RACE:$RACE upgraded to Hold at Evercore ISI Group

6. RXN:Baird Upgrades Rexnord $RXN to Outperform

7. SNHY:Baird Upgrades Sun Hydraulics $SNHY to Outperform

8. SXL:Bernstein Upgrades Sunoco Logistics Partners $SXL to Market Perform

9. SYY:BofA/Merrill Lynch Upgrades Sysco $SYY to Buy

10. TTM:Credit Suisse Upgrades Tata Motors $TTM to Outperform

DOWNGRADES

1. BBY:Evercore ISI Downgrades Best Buy $BBY to Sell

2. CEMP:$CEMP — Andy Berens from MS downgrades to underweight from overweight, PT to $5 from $35.

3. DEPO:Cantor Fitzgerald Downgrades Depomed to Hold $DEPO

4. GS:$GS downgraded to Neutral at Citigroup

5. MT:BofA/Merrill Lynch Downgrades Arcelor Mittal $MT to Neutral

6. N:JMP Securities Downgrades NetSuite $N to Market Perform

7. OMF:Wedbush Downgrades OneMain $OMF to Neutral

8. PRAA:Raymond James Downgrades Portfolio Recovery Associates $PRAA to Market Perform

9. RMTI:BofA/Merrill Lynch Downgrades Rockwell Medical Technologies $RMTI to Underperform

EARNINGS

1. PRIM:$PRIM reports FQ3 earnings of 22c EPS and $507.83M Revs –

2. W:$W reports FQ3 earnings of -51c EPS and $861.53M Revs –

3. LGIH:$LGIH reports FQ3 earnings of 86c EPS and $216.30M Revs –

4. WLK:$WLK reports FQ3 earnings of 86c EPS and $1.28B Revs –

5. TAST:$TAST reports FQ3 earnings of 13c EPS and $238.87M Revs –

6. JCI:$JCI reports FQ4 earnings of $1.21 EPS and $10.22B Revs –

7. DHI:$DHI reports FQ4 earnings of 75c EPS and $3.65B Revs –

8. AER:$AER reports FQ3 earnings of $1.68 EPS and $1.23B Revs –

9. CRK:$CRK reports FQ3 earnings of $-2.32 EPS and $50.33M Revs –

10. TA:$TA reports FQ3 earnings of 28c EPS and $1.48B Revs –

11. TA:$TA reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $37.63M –

12. SEAS:$SEAS reports FQ3 earnings of 77c EPS and $485.32M Revs –

13. CVS:$CVS reports FQ3 earnings of $1.64 EPS and $44.62B Revs –

14. LIOX:$LIOX reports FQ3 earnings of 13c EPS and $135.18M Revs –

15. HL:$HL reports FQ3 earnings of 7c EPS and $179.39M Revs –

16. HL:$HL reports inline with the Estimize EPS Consensus and beats the Estimize Revenue Consensus by $12.02M –

17. SATS:$SATS reports FQ3 earnings of 39c EPS and $742.35M Revs –

18. HGG:$HGG reports FQ2 earnings of -51c EPS and $454.50M Revs –

19. ENDP:$ENDP reports FQ3 earnings of $1.01 EPS and $884.34M Revs –

20. CNK:$CNK reports FQ3 earnings of 56c EPS and $768.57M Revs –

21. ATRO:$ATRO reports FQ3 earnings of 41c EPS and $155.10M Revs –

22. VRX:$VRX reports FQ3 earnings of $1.55 EPS and $2.48B Revs –

Trending Social Alerts

1. HTZ:Hertz Global Holdings, Inc. 2016 Q3 – Results – Earnings Call Slides $HTZ

2. VRX:Valeant Pharmaceuticals Q4 earnings Adj EPS $1.55 Revenue $2.48 bln $VRX

3. CVS:CVS Health beats by $0.07, misses on revenue #premarket $CVS

4. OREX:$OREX $VRX .. Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave®

Trending News Headlines

1. Andy Biotech on Twitter

“$VRX cuts EPS guidance by >20%, driven by issues in every segment of business…”

2. Tesla acquires Grohmann engineering to boost production

Tesla just announced that it will acquire Germany’s Grohmann Engineering, in a deal that will see the global engineering leader become Tesla’s new Advanced..

3. Valeant Goes Back to Slashing Guidance

Valeant returned to slashing its annual outlook, signaling the pharmaceutical company is still hemorrhaging from missteps over the past year despite efforts to remake its business.

4. Leaked documents shed light on the defunct pharmacy that brought Valeant to its knees

Valeant had a sales plan dubbed the “Philidor strategy” to use the pharmacy and increase the volume of shipments for two of its drugs, Solodyn and Jublia.

5. howardlindzon on Twitter

“Why Twitter must be saved …from @benthompson $twtr $fb (sadly mostly from itself)”

6. Tesla to buy Grohmann Engineering to ramp up automated manufacturing

Electric carmaker Tesla Motors Inc (TSLA.O) said on Tuesday it would buy German firm Grohmann Engineering to improve its automated manufacturing systems.

7. A watershed moment for marijuana legalization

Referenda on marijuana legalization in five states may turn out to be a milestone in the struggle against drug prohibition.

8. The Priceline Group (PCLN) PT Raised to $1800 at Jefferies

Jefferies analyst Brian Fitzgerald reiterated a Buy rating and raised his price target on The Priceline Group (NASDAQ: PCLN) to $1,800.00 (from $1,700.00).Fitzgerald commented, “PCLN reported another solid…

Technology News

1. #China on Mon. adopted a Cybersecurity Law to safeguard sovereignty on cyber space

2. Titanfall 2 runs at 1440p on PlayStation 4 PRO –

3. Twitter has received offers to sell @Vine, which costs $10M a month to run.

4. Tesco Bank’s chief executive blames ‘systematic, sophisticated attack’ for money taken from 20,000 accounts – BBC

5. Little scoop from last night. Not a full acquisition, but I confirmed Apple did buy parts of Omnifone this year

6. Chinese billionaire who wants to beat Elon Musk at his own game admits his company is running out of cash

7. Apple should do this with CarPlay

8. Apple News update increases publishers traffic; CNN’s section received 36.5M uniques in Sept

9. Whenever a #bank is subject to #cybercrime the attack is always ‘sophisticated’ & never due to their weak #Security

PRE-MARKET | November 07, 2016 | $AAPL, $MGM, $HSBC, $BA, $BIDU, $CMG, $MSFT, $TSLA, $BIIB, $BID

PRE-MARKET | November 07, 2016 | $AAPL, $MGM, $HSBC, $BA, $BIDU, $CMG, $MSFT, $TSLA, $BIIB, $BID

by Alpha | Nov 7, 2016 | Pre-Market

PRE-MARKET MOVERS

1. CEMP:

$CEMP FDA panel, by a whisker, votes yes on Cempra’s antibiotic – Fierce Biotech

2. N, ORCL:

$N Oracle $ORCL Announces Completion of NetSuite Tender Offer – Street Insider

3. DTLK, NSIT:

$DTLK Insight Enterprises $NSIT to acquire Datalink for $11.25 per share in cash – Reuters

4. LCI:

$LCI LendingClub’s stock jumps after results beat expectations – MarketWatch

5. LC:

$LC LendingClub’s stock jumps after results beat expectations – MW

6. RACE:

$RACE Ferrari Q3 Profit Rises; Lifts 2016 Outlook – RTT

7. MGM:

$MGM MGM Resorts Tops Q3 EPS Views; MGM China Revenue Sank 6% – SI

8. HSBC:

$HSBC HSBC Jumps On Stronger Q3 Capital Buffer – Barron’s

9. ARIA:

$ARIA ARIAD Reports Third Quarter 2016 Financial Results – Business Wire

10. HZNP:

$HZNP Horizon Pharma Tops Q3 EPS by 7c – SI

11. ELNK, WIN:

$WIN Windstream, EarthLink $ELNK Enter $1.1B Merger Agreement – Street Insider

12. RIO:

$RIO Rio Tinto sees record price for diamonds tender – MarketWatch

13. BABA:

$BABA Alibaba looks to expand Singles Day shopping spree beyond China – FT

14. SYY:

$SYY Sysco Corp. Tops Q1 EPS by 9c – Street Insider

15. BIDU:

$BIDU Baidu to Seek Up to $500 Million for Waimai Delivery Unit – BBG

16. BA:

$BA China Exclusive: Boeing celebrates innovative strategic partnership with China – Xinhua

17. CRM, LNKD, MSFT:

$CRM How LinkedIn $LNKD Drove a Wedge Between Microsoft $MSFT and Salesforce – NYTimes

18. AMGN:

$AMGN FDA approves Amgen’s Enbrel to treat children with plaque psoriasis – PBR

19. CMG:

$CMG Chipotle, Ackman talks intensify with confidentiality agreement – CNBC

20. BRK:

$BRK/B Berkshire Hathaway Reports Higher Revenue – WSJ

21. TM, TSLA:

$TM Toyota is planning long-range battery-powered electric cars for 2020 $TSLA – Electrek

22. BURL: $BURL Burlington Stores denies claims made by activist investor Spruce Point Capital – MW

23. FNBC: $FNBC First NBC Bank Weighing Capital Raising or Sale – WSJ

24. PLUG:

$PLUG Plug Power misses estimates – SA

25. CXRX:

$CXRX Concordia International Misses Q3 EPS by 35c; Guidance Suspended – Street Insider

26. NILE: $NILE Blue Nile to be bought out by Bain for $500 million, a 34% premium for shareholders – MW

UPGRADES

1. AMED:Mizuho Securities Upgrades Amedisys $AMED to Buy; Sell-Off Excessive

2. BIIB:$BIIB upgraded to Overweight at PiperJaffray

3. CBM:First Analysis Upgrades Cambrex Corporation $CBM to Overweight

4. CGNX:CLSA Upgrades Cognex $CGNX to Outperform

5. CMI:Evercore ISI Upgrades Cummins $CMI to Buy

6. CRZO:KLR Group Upgrades Carrizo Oil & Gas $CRZO to Buy Following Recent Sell-Off

7. CYBR:$CYBR upgraded to Outperform at Imperial Capital – PT $55

8. DOC:Raymond James Upgrades Physicians Realty Trust $DOC to Strong Buy

9. HTA:Raymond James Upgrades Healthcare Trust of America $HTA to Outperform

10. LITE:Raymond James Upgrades Lumentum $LITE to Strong Buy

11. MITT:AG Mortgage upgraded at Wunderlich

12. PAH:Nomura Securities Upgrades Platform Specialty Products $PAH to Buy; Deep Discount and Return to …

13. PBPB:Maxim Group Upgrades Potbelly Corp $PBPB to Buy

14. TWX:$TWX upgraded to Outperform at Credit Suisse – PT $107.50

DOWNGRADES

1. ABCO:BofA/Merrill Lynch Downgrades Advisory Board Company $ABCO to Underperform

2. AEO:BlueFin Downgrades American Eagle to Hold $AEO

3. CHFN:Keefe, Bruyette & Woods Downgrades Charter Financial $CHFN to Market Perform

4. CLH:Clean Harbors downgraded to equal weight from overweight at Barclays. Price target cut to $49 from $58. $CLH 11/4 c…

5. GPRO:$GPRO downgraded to Underperform at Bank of America

6. TEVA:$TEVA downgraded to Neutral at Bank of America

7. XRX:Xerox’s Printing Business Continues To Underperform; Morgan Stanley Downgrades Stock

EARNINGS

1. HAE:$HAE reports FQ2 earnings of 46c EPS and $220.25M Revs –

2. LNCE:$LNCE reports FQ3 earnings of 35c EPS and $588.80M Revs –

3. PEGI:$PEGI reports FQ3 earnings of -5c EPS and $91.91M Revs –

4. MTRX:$MTRX reports FQ1 earnings of 35c EPS and $341.78M Revs –

5. EPAM:$EPAM reports FQ3 earnings of 76c EPS and $298.29M Revs –

6. LC:$LC reports FQ3 earnings of -4c EPS and $112.61M Revs –

7. HYGS:$HYGS reports FQ3 earnings of -15c EPS and $6.73M Revs –

8. HYGS:$HYGS reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $4.66M –

9. SN:$SN reports FQ3 earnings of 14c EPS and $114.81M Revs –

10. HZNP:$HZNP reports FQ3 earnings of 70c EPS and $273.70M Revs –

11. RBC:$RBC reports FQ3 earnings of $1.31 EPS and $819.30M Revs –

12. SNI:$SNI reports FQ3 earnings of $1.26 EPS and $803.09M Revs –

13. ROK:$ROK reports FQ4 earnings of $1.52 EPS and $1.54B Revs –

14. WIN:$WIN reports FQ3 earnings of -46c EPS and $1.35B Revs –

15. ARIA:$ARIA reports FQ3 earnings of -12c EPS and $46.02M Revs –

16. BID:$BID reports FQ3 earnings of -78c EPS and $91.49M Revs –

17. MEET:$MEET reports FQ3 earnings of 10c EPS and $17.19M Revs –

18. MEET:$MEET reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $0.22M –

19. PGEM:$PGEM reports FQ3 earnings of 75c EPS and $530.39M Revs –

20. SHEN:$SHEN reports FQ3 earnings of 26c EPS and $156.84M Revs –

21. CORE:$CORE reports FQ3 earnings of 37c EPS and $3.99B Revs –

22. HSNI:$HSNI reports FQ3 earnings of 52c EPS and $823.02M Revs –

23. HSNI:$HSNI reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $4.02M –

24. TTI:$TTI reports FQ3 earnings of -5c EPS and $176.55M Revs –

25. VSH:$VSH reports FQ3 earnings of 25c EPS and $591.96M Revs –

26. VSH:$VSH reports inline with the Estimize EPS Consensus and misses the Estimize Revenue Consensus by $2.49M –

27. MGM:$MGM reports FQ3 earnings of 35c EPS and $2.52B Revs –

28. FDC:$FDC reports FQ3 earnings of 34c EPS and $1.82B Revs –

29. SYY:$SYY reports FQ1 earnings of 63c EPS and $13.97B Revs –

30. ELNK:$ELNK reports FQ3 earnings of -2c EPS and $235.13M Revs –

31. DF:$DF reports FQ3 earnings of 37c EPS and $1.97B Revs –

32. SEMG:$SEMG reports FQ3 earnings of -14c EPS and $327.76M Revs –

Trending Social Alerts

1. BIIB:Piper’s Schimmer lists collusion focus potentially shifting to MS as risk in $BIIB upgrade

2. CEMP:$CEMP antibiotic approval still in doubt even with positive fda panel vote

3. NILE:$NILE -10% on Friday; acquired by Bain at $40.75 on Monday. The game is hard

4. N:$N Halted, news pending

5. ELNK:Windstream $WIN, EarthLink $ELNK Enter $1.1B Merger Agreement $$

6. CXRX:Concordia misses estimates by wide margin $0.69 vs $1.04 expected Will no longer provide financial forecasts $CXRX $CXR.TO

7. IONS:$BIIB & $IONS Announce SPINRAZA Meets Primary Endpoint at Interim Analysis of P3 CHERISH Study in Later-Onset SMA

Trending News Headlines

1. Cempra antibiotic approval still in doubt even with positive fda panel vote

By a slim 7-6 margin, experts convened by the FDA decided the benefits of solithromycin outweighed its potential safety problems in treating patients with community-acquired bacterial pneumonia.

2. MGM Resorts (MGM) Tops Q3 EPS Views; MGM China Revenue Sank 6%

MGM Resorts (NYSE: MGM) reported Q3 EPS of $0.53, $0.42 better than the analyst estimate of $0.11. Revenue for the quarter came in at $2.52 billion versus the consensus estimate of $2.38…

3. Banks Passed Up Uber Share Sale on Lack of Data

The potential fees and reputation boost that could come from working on Uber Technologies Inc.’s initial public offering are the stuff of bankers’ dreams.

4. Biotech portfolio updates – ESMO 2016, Exelixis, Abeona, Esperion and Seattle Genetics | Open Reading Frame

After a two-month break here is a recap of key highlights from the September/October time frame. On the menu today: PD-1 controversies at ESMO 2016, Exelixis’ ( EXEL ) launch in renal cancer, gene therapy data from Abeona ( ABEO ), long awaited update from Esperion ( ESPR ) and a positive surprise from Seattle Genetics ( SGEN ).

5. FDA panel, by a whisker, votes yes on Cempra’s antibiotic | FierceBiotech

An FDA panel has voted 7-6 that Cempra’s new antibiotic solithromycin should be recommended for U.S. regulatory approval–coming days after its shares plummeted by 40% on safety fears.

6. Bain Capital, Bow Street-Led Investor Group to Acquire Blue Nile (NILE) for $40.75/Share

Leading online jeweler Blue Nile (Nasdaq: NILE), announced that it has entered into a definitive agreement to be acquired by an Investor Group comprised of funds managed by…

7. Meg Tirrell on Twitter

“Piper’s Schimmer lists collusion focus potentially shifting to MS as risk in $BIIB upgrade”

8. Windstream (WIN), EarthLink (ELNK) Enter $1.1B Merger Agreement

Windstream Holdings, Inc. (Nasdaq: WIN) and EarthLink Holdings Corp. (Nasdaq: ELNK) announced that their boards of directors have unanimously approved a definitive merger…

Technology News

1. NBC News: U.S. military hackers have penetrated Russia’s electric grid, telecom networks & Kremlin’s command systems

2. Governments and large companies are exploring blockchain tech—but not because they want to use digital currency.

3. Fascinating to watch the US try to establish cyber deterrence in real time, out in the open

4. Privacy + security + community peeps, we’ve got work to do: Virtual Reality Isn’t Ready To Handle Abusive Trolls

5. Oculus, whose founder donated money to the alt-right, did not want to talk to us about our VR harassment story

6. 1. Funny Google claim: 58 carriers, “and manufacturers” (?!), for 4.7B people support standard RCS

7. Thousands of Tesco bank customers are thought to be affected, some have had £100s taken from their accounts:

8. Maybe if we complain a little bit more they will add the Escape key back?

9. Interesting Tho REALLY ought show cashflow+profitability If founder cant run a biz to make cash they must raise it